Humacyte, Inc. (HUMA) NASDAQ

1.81

+0.094(+5.47%)

Updated at October 20 12:30PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-4.56
PEG Ratio-0.13
Price/Sales Ratio33.88
Price/Book Ratio65.98
Enterprise/Revenue31.03
Enterprise/EBITDA-6.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-7.29
Operating Margin-13.82

Management Effectiveness

Return On Assets-0.42
Return On Equity3.08

Income Statement

Revenue0
Revenue/Share0.05
Gross Profit-7.19M
EBITDA-132.23M
Net Income-148.7M
Diluted EPS-1.26

Balance Sheet

Total Cash38.03M
Total Cash/Share0.24
Total Debt15.12M
Total Debt/Equity3.73
Current Ratio2.45
Book Value Per Share0.03

Price History

52-Week Change-67.79
52-Week High6.77
52-Week Low1.15
Moving Average 50 Days1.68
Moving Average 200 Days2.49

Statistics

Average Volume5.55M
Shares Outstanding158.47M
% Held by Institutions34.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A